000			01434 a2200385 4500
005			20250510210116.0
264		0	_c19761001
008			197610s 0 0 eng d
022			_a0025-7125
024	7		_a10.1016/s0025-7125(16)31847-8 _2doi
040			_aNLM _beng _cNLM
100	1		_aPasmantier, M W
245	0	0	_aChemotherapy of the non-Hodgkin's lymphomas. _h[electronic resource]
260			_bThe Medical clinics of North America _cSep 1976
300			_a1043-52 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aBleomycin _xtherapeutic use
650	0	4	_aChlorambucil _xtherapeutic use
650	0	4	_aCortisone _xtherapeutic use
650	0	4	_aCyclophosphamide _xtherapeutic use
650	0	4	_aDoxorubicin _xtherapeutic use
650	0	4	_aDrug Therapy, Combination
650	0	4	_aHumans
650	0	4	_aLymphoma _xclassification
650	0	4	_aMechlorethamine _xtherapeutic use
650	0	4	_aMethotrexate _xtherapeutic use
650	0	4	_aStreptonigrin _xtherapeutic use
650	0	4	_aVinblastine _xtherapeutic use
650	0	4	_aVincristine _xtherapeutic use
700	1		_aColeman, M
700	1		_aSilver, R T
773	0		_tThe Medical clinics of North America _gvol. 60 _gno. 5 _gp. 1043-52
856	4	0	_uhttps://doi.org/10.1016/s0025-7125(16)31847-8 _zAvailable from publisher's website
999			_c58401 _d58401